Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
0.9826
0.00 (0.00%)
Dec 31, 2025, 4:00 PM EST - Market closed
Fate Therapeutics Market Cap
Fate Therapeutics has a market cap or net worth of $113.35 million as of January 2, 2026. Its market cap has decreased by -45.61% in one year.
Market Cap
113.35M
Enterprise Value
-22.83M
1-Year Change
-45.61%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since October 1, 2013, Fate Therapeutics's market cap has decreased from $126.10M to $113.35M, a decrease of -10.11%. That is a compound annual growth rate of -0.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 113.40M | -39.65% |
| Dec 31, 2024 | 187.90M | -49.05% |
| Dec 29, 2023 | 368.80M | -62.38% |
| Dec 30, 2022 | 980.40M | -82.45% |
| Dec 31, 2021 | 5.59B | -29.57% |
| Dec 31, 2020 | 7.93B | 436.27% |
| Dec 31, 2019 | 1.48B | 78.70% |
| Dec 31, 2018 | 827.80M | 225.01% |
| Dec 29, 2017 | 254.70M | 197.20% |
| Dec 30, 2016 | 85.70M | -11.47% |
| Dec 31, 2015 | 96.80M | -6.47% |
| Dec 31, 2014 | 103.50M | -19.01% |
| Dec 31, 2013 | 127.80M | 1.35% |
| Oct 1, 2013 | 126.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 968.54B |
| Johnson & Johnson | 498.15B |
| AbbVie | 405.63B |
| UnitedHealth Group | 300.86B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 262.75B |
| Novo Nordisk | 227.63B |